Kymera Therapeutics | 8-K: Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update
May 2 07:13 ET
Kymera Therapeutics | DEFA14A: Others
Apr 24 16:16 ET
Kymera Therapeutics | DEF 14A: Definitive information statements
Apr 24 16:09 ET
Kymera Therapeutics | 8-K: Current report
Apr 1 07:05 ET
Kymera Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 22 07:36 ET
Kymera Therapeutics | 8-K: Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
Feb 22 07:11 ET
Kymera Therapeutics | 8-K: Current report
Jan 5 00:00 ET
Kymera Therapeutics | 8-K: Current report
Jan 4 00:00 ET
Kymera Therapeutics | 8-K: Current report
Jan 4 00:00 ET
Kymera Therapeutics | 8-K: Current report
Nov 2, 2023 09:15 ET
Kymera Therapeutics | 8-K: Kymera Therapeutics Announces Third Quarter 2023 Financial Results and Provides a Business Update
Nov 2, 2023 07:10 ET
Kymera Therapeutics | 8-K: Kymera Therapeutics Announces Second Quarter 2023 Financial Results and Provides a Business Update
Aug 3, 2023 07:10 ET
Kymera Therapeutics | 8-K: Current report
Jun 16, 2023 16:06 ET
Kymera Therapeutics | 8-K: Current report
May 22, 2023 16:45 ET
Kymera Therapeutics | 8-K: Kymera Therapeutics Announces First Quarter 2023 Financial Results and Provides a Business Update
May 4, 2023 07:10 ET
Kymera Therapeutics | DEFA14A: Others
Apr 27, 2023 16:10 ET
Kymera Therapeutics | DEF 14A: Definitive proxy statements
Apr 27, 2023 16:06 ET
Kymera Therapeutics | 8-K: Current report
Mar 10, 2023 17:30 ET
Kymera Therapeutics | 8-K: Current report
Feb 27, 2023 17:22 ET
Kymera Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 23, 2023 07:31 ET
No Data
No Data